Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Conduct a value analysis of cash back cards with no fees to make smart financial choices. Understand the benefits and options available.
25,276 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Two investing legends, two starkly different takes on Amazon. This article breaks down the contrasting approaches, wh...
Nike has been a market darling, then hit a rough patch. This article digs into whether nike stock undervalued right n...
Netflix backed away from a Warner Bros. deal, signaling a calculated shift in strategy. Here are five practical reaso...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...
When a bank’s CEO retiires and a director sells shares, investors take notice. This article breaks down what that mov...
A new cross-asset note from Morgan Stanley says AI will reshape jobs rather than wipe them out, pushing workers towar...
A New York Fed tariff study finds most costs fall on U.S. businesses and consumers, prompting Kevin Hassett to demand...
AI-powered assessments converge on a cautiously optimistic view for XRP, with key support holding and an upside path ...
A wave of AI-driven efficiency moves is prompting banks to trim payrolls. The trend rekindles a widely circulated war...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
A new realtor.com analysis questions whether a Senate plan to curb large investors in single-family homes will meanin...